Politics professor's company fights SARS
Donald Drakeman GS '88, politics professor and former lawyer, is now at the forefront of developing a treatment for Severe Acute Respiratory Syndrome.His company, Princeton-based pharmaceutical business Medarex, joined forces with the Massachusetts Biologic Laboratories of the University of Massachusetts Medical School late last month to create wholly human antibodies to SARS.SARS ? a respiratory illness that has recently been reported in Europe, Asia and North America ? has as of yesterday caused more than 6,500 cases and close to 500 deaths, according to the World Health Organization."We believe that development of a fully human neutralizing antibody to the SARS virus may be a relatively rapid approach to obtain an agent that can limit the disease in infected and exposed individuals," said Israel Lowy, director of infectious diseases at Medarex, in a press release.Drakeman and Mark Shelton of the UMass press office said the lab and the company were compatible because of their similar research in genetic engineering.The MBL is the only nonprofit Food and Drug Administration-licensed manufacturer of vaccines and other biologic products in the United States, according to a press release on Medarex's website.




